P Cappelaere

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

M. Clavel, Jan B. Vermorken, F. Cognetti et al. · Annals of Oncology · 1994 · 278 citations · Full text

A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy

B. Audhuy, P Cappelaere, Miquel Martín et al. · European Journal of Cancer · 1996 · 85 citations

Anti-emetic Efficacy, Medicine, Metronomic Therapy +8

Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.

Jan H. Schornagel, Jaap Verweij, P H de Mulder et al. · Journal of Clinical Oncology · 1995 · 78 citations

Prolactin receptors in human breast cancer

Jacques Bonneterre, Jean‐Philippe Peyrat, B. Vandewalle et al. · European Journal of Cancer and Clinical Oncology · 1982 · 47 citations

Breast Oncology, Hormonal Receptor, Pathology +6

Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: Results of a double blind multicentre clinical trial

Jacques Bonneterre, L. Mauriac, B. Weber et al. · European Journal of Cancer and Clinical Oncology · 1988 · 46 citations

Advanced Breast Cancer, Breast Oncology, Oncology +9